Seattle Cancer care Alliance

What Seattle Cancer care Alliance does

Fred Hutchinson Cancer Center (operating under the legacy name Seattle Cancer Care Alliance until the 2022 integration) is a 501(c)(3) nonprofit, NCI-class-equivalent comprehensive cancer center headquartered in Seattle, Washington, founded in 1975. The organization delivers integrated cancer research and clinical care across the Pacific Northwest, operating a portfolio of treatment modalities that includes blood and marrow transplantation, immunotherapy, medical oncology, radiation oncology, surgical oncology, proton therapy, CRS-HIPEC, radiology, and supportive care services, complemented by more than 750 active clinical trials — the largest such portfolio of any medical center in the region. Fred Hutch also operates community-based clinical sites in Kirkland, Bellevue, and Issaquah through partnerships with EvergreenHealth and Overlake, and serves as the designated cancer program for UW Medicine.

Its core technology stack centers on translational research — cell and gene therapy, hematopoietic transplantation, immunotherapy, vaccine development, virology, and data sciences — which feeds directly into clinical delivery through integrated research-and-care pathways. The organization maintains research divisions in Basic Sciences, Clinical Research, Human Biology, and Public Health Sciences, supported by specialized infrastructure in biostatistics, epidemiology, and genomics that underpins both trial design and personalized treatment protocols.

Fred Hutch generates revenue through three principal streams: clinical care services billed to insurance and patients (with financial assistance programs available), philanthropic donations (direct giving, monthly giving, donor-advised funds, legacy giving, corporate philanthropy, and fundraising events such as Obliteride and Base 2 Space), and research grants from government and private funders. Patient acquisition occurs through direct phone scheduling, online appointment requests via MyChart, provider referrals, telehealth visits, and distributed clinical locations across the Seattle metropolitan area. The go-to-market motion is therefore enterprise-field-sales in structure — physician-led, referral-driven, and regionally distributed — with a 501(c)(3) tax-exempt operating model rather than a venture-backed commercial structure.

Name

Seattle Cancer care Alliance

Legal name

Fred Hutchinson Cancer Center

Website

https://seattlecca.org

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Fred Hutchinson Cancer Center (formerly Seattle Cancer Care Alliance) is a Seattle-based 501(c)(3) nonprofit comprehensive cancer center delivering research-driven treatment, immunotherapy, bone marrow transplant, proton therapy, and more than 750 active clinical trials to Pacific Northwest patients across multiple regional clinical sites.

Ownership category

akta.pro rank

Product category

Oncology Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (62231), General Medical and Surgical Hospitals (622110), Offices of Physicians (62111), Offices of Physicians (except Mental Health Specialists) (621111)

SIC

Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Medical Oncology (HLAKAFAB), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Cancer treatment services
• Oncology care
• Clinical research trials
• Bone marrow transplant
• Immunotherapy services

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Care Services: Revenue from providing cancer treatment services including chemotherapy, radiation, surgery, transplants, and supportive care to patients. Services billed through insurance and financial assistance programs.
2. Philanthropy and Donations: 501(c)(3) nonprofit organization accepting donations through various programs including direct giving, monthly giving, donor-advised funds, legacy giving, corporate philanthropy, and fundraising events like Obliteride and Base 2 Space
3. Research Grants and Funding: Government and private research funding for scientific research programs

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

Fred Hutchinson Cancer Center (formerly Seattle Cancer Care Alliance) provides comprehensive cancer diagnosis, treatment, and supportive care services across multiple modalities — including medical oncology, radiation oncology, surgical oncology, immunotherapy, blood and marrow transplantation, proton therapy, and CRS-HIPEC. The organization complements its clinical care with a research enterprise of more than 750 active clinical trials and serves as the cancer program for UW Medicine, operating clinical sites across the Pacific Northwest.

Product overview

Fred Hutchinson Cancer Center is a comprehensive cancer care and research organization offering a unified portfolio of treatment services spanning multiple modalities. The core clinical services include blood and marrow transplant, immunotherapy, medical oncology, radiation oncology, surgical oncology, proton therapy, CRS-HIPEC, and radiology—each functioning as a distinct treatment service line. These are complemented by patient support services including telehealth appointments, the Fred Hutch Pharmacy, and a mobile mammogram van for community-based screening. The organization distinguishes itself through its research enterprise, offering access to over 750 active clinical trials—the most of any medical center in the Pacific Northwest. Fred Hutch serves as the cancer program for UW Medicine and provides care at multiple clinical sites throughout the Seattle region.

Differentiator

Problem solved

Functional benefit

Products and services

• Blood and Marrow Transplant

Quantifiable outcome

• More than 750 active treatment trials - more than any other medical center in the Pacific Northwest
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• UW MedicinecoreStrategic or Co-development PartnerFred Hutch is an independent organization that serves as UW Medicine's cancer program. This partnership integrates Fred Hutch's research excellence with UW Medicine's clinical care delivery system, providing comprehensive cancer services through the partnership.
• EvergreenHealthcoreStrategic or Co-development PartnerPartnership providing cancer care on the Eastside of King County. Fred Hutch locations in Kirkland operate in partnership with EvergreenHealth to meet patients in the community.
• Overlake Medical CentercoreStrategic or Co-development PartnerPartnership providing cancer care on the Eastside of King County. Fred Hutch locations in Bellevue and Issaquah operate in partnership with Overlake to expand access to cancer care services in the community.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• MD Anderson Cancer Center: One of the largest and highest-ranked NCI-designated comprehensive cancer centers in the U.S. Directly comparable as a specialty oncology hospital and research institution offering multi-modality treatment and hundreds of clinical trials — the relevant benchmark for Fred Hutch's clinical and research model at national scale.
• Memorial Sloan Kettering Cancer Center: Premier NCI-designated specialty cancer hospital combining research and patient care across surgery, medical oncology, radiation oncology, and immunotherapy. Directly comparable on specialty hospital focus, translational research intensity, and clinical trial volume.
• Dana-Farber Cancer Institute: NCI-designated specialty cancer center affiliated with Harvard and Brigham and Women's Hospital. Highly comparable as a research-driven oncology specialty hospital with a large clinical trial portfolio and deep academic partnership.
• City of Hope National Medical Center: NCI-designated specialty cancer hospital with a strong translational research program in immunotherapy, bone marrow transplant, and cell therapy. Directly comparable in service mix, clinical trial breadth, and specialty hospital focus.
• Roswell Park Comprehensive Cancer Center: One of the original NCI-designated comprehensive cancer centers, operating as a specialty oncology hospital and research institute. Comparable in combining inpatient specialty oncology care with a large clinical trial portfolio.
• UCSF Helen Diller Family Comprehensive Cancer Center: NCI-designated comprehensive cancer center at UCSF offering specialty oncology care, translational research, and clinical trials. Comparable as a West Coast academic cancer center with a similar research-care integration model.

Broad incumbents

• Mayo Clinic Comprehensive Cancer Center: Cancer program within the broader Mayo Clinic health system, offering oncology care across all modalities alongside general medical/surgical services. Comparable in clinical trial scale and integrated research-care model, though embedded in a much larger multi-specialty system.
• Stanford Cancer Institute: NCI-designated cancer center within Stanford Medicine, combining oncology specialty care with broad academic medical center resources. Comparable in translational research focus and West Coast positioning, though embedded in a larger health system.

Regional players

• OHSU Knight Cancer Institute: NCI-designated comprehensive cancer center at Oregon Health & Science University, serving the Pacific Northwest. Comparable as a regional academic cancer center with overlapping patient geography, though based in Oregon rather than Washington.
• Huntsman Cancer Institute: NCI-designated comprehensive cancer center at the University of Utah with specialty oncology care and a significant research enterprise. Comparable as an academic-affiliated specialty cancer center with a regional footprint, though serving the Mountain West rather than the Pacific Northwest.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/seattlecca
• Facebookfacebook.com/seattlecancercarealliance
• LinkedInlinkedin.com/company/seattle-cancer-care-alliance

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Seattle Cancer care Alliance